TMCnet News

Dynamics Within Industry-Academia Partnerships Changing - Research and Markets
[June 20, 2016]

Dynamics Within Industry-Academia Partnerships Changing - Research and Markets


Research and Markets has announced the addition of the "Cancer Drug News Issue 666" report to their offering.

The favourable terms for academia in the deal highlight a shift in dynamics in industry-academia partnership. As more big pharma companies seek to leverage open innovation to drive lower cost, faster and more flexible R&D, competition for top institutions will increase. We expect a move away from academia being seen as just a provider of early research for the industry, towards more equally weighted partnerships.

Key Topics Covered:

  1. Dynamics Within Industry-Academia Partnerships Changing
  2. CHMP Adopts Positive Opinion On Empliciti For MM
  3. Kyprolis Approvd For Multiple Myeloma In Canada
  4. Bendeka Available In US
  5. Venetoclax Receives FDA Breakthrough Therapy Designation For AML
  6. Cabozantinib Will Encounter Toughening Market Environment Despite Swift (News - Alert) Entry
  7. Tookad Filed For Approval In Mexico Following Positive Phase III Results In PCA
  8. AstraZeneca's Lynparza Drive Will Secure Sustained Revenue Growth
  9. Stelba Submits Tookad MAA To EMA (News - Alert)
  10. Jakafi Phase II Substudy Stopped Early Due To Insufficient Efficacy
  11. Halozyme Raises Funds To Continue Oncology Development
  12. Sun Launches Imatinib Mesylate In US
  13. HUYA Grants Exclusive Licence For HBI-8000 To Eisai
  14. Aduro Receives Clinical Development Milestone Payments From Janssen
  15. FDA Approves Eisai's Halaven For Advanced Liposarcoma
  16. Adicet Raises Funds; Acquires Applied Immune Technologies
  17. Spectrum (News - Alert) Initiates SPI-2012 Phase III Trial Chemotherapy-Induced Neutropenia In BC
  18. Strong Oncology Profile To Support 2016 Growth


For more information visit http://www.researchandmarkets.com/research/mkptcr/cancer_drug_news



[ Back To TMCnet.com's Homepage ]